Health implications of high dietary omega-6 polyunsaturated Fatty acids.

Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. · 2012

Read Health implications of high dietary omega-6 polyunsaturated Fatty acids. by Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3335257.txt.

Introduction

Patterson, Wall, Fitzgerald, Ross, and Stanton reviewed the health effects of eating large amounts of omega-6 fats, in a 2012 article. Omega-6 and omega-3 fats are raw material for potent signaling molecules that steer inflammation. Those built from omega-6 fats generally promote inflammation, while omega-3 based ones calm it.

Western diets have shifted over recent decades until omega-6 intake outweighs omega-3 by roughly fifteen to one, tilting the body's signaling toward the inflammatory side. Over the same period, chronic inflammatory conditions have climbed, including fatty liver disease, heart disease, obesity, bowel inflammation, arthritis, and Alzheimer disease. The authors argue that rebalancing the diet toward omega-3 fats could trim the incidence of these conditions, and they survey the evidence linking the fat ratio to each disease.

Catalog record

CREATORPatterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3335257

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids By E Patterson, R Wall, G F Fitzgerald, R P Ross, C Stanton Published in: Journal of Nutrition and Metabolism DOI: 10.1155/2012/539426 ABSTRACT Abstract Omega-6 (n-6) polyunsaturated fatty acids (PUFA) (e.g., arachidonic acid (AA)) and omega-3 (n-3) PUFA (e.g., eicosapentaenoic acid (EPA)) are precursors to potent lipid mediator signalling molecules, termed “eicosanoids,” which have important roles in the regulation of inflammation. In general, eicosanoids derived from n-6 PUFA are proinflammatory while eicosanoids derived from n-3 PUFA are anti-inflammatory. Dietary changes over the past few decades in the intake of n-6 and n-3 PUFA show striking increases in the (n-6) to (n-3) ratio (~15 : 1), which are associated with greater metabolism of the n-6 PUFA compared with n-3 PUFA. Coinciding with this increase in the ratio of (n-6) : (n-3) PUFA are increases in chronic inflammatory diseases such as nonalcoholic fatty liver disease (NAFLD), cardiovascular disease, obesity, inflammatory bowel disease (IBD), rheumatoid arthritis, and Alzheimer's disease (AD). By increasing the ratio of (n-3) : (n-6) PUFA in the Western diet, reductions may be achieved in the incidence of these chronic inflammatory diseases. 1. INTRODUCTION Fatty acids are hydrocarbon chains with a carboxyl group at one end and a methyl group at the other. The biological reactivity of fatty acids is defined by the length of the carbon chain and by both the number and position of any double bonds present. While saturated fatty acids do not contain double bonds within the acyl chain, unsaturated fatty acids contain at least one double bond. When two or more double bonds are present, unsaturated fatty acids are referred to as PUFA [1]. There are two families of PUFA, and they are classified as omega-3 (n-3) and omega-6 (n-6) based on the location of the last double bond relative to the terminal methyl end of the molecule [2]. The human body can produce all but two of the fatty acids it requires. Linoleic acid (LA, C18:2n-6) (precursor to the n-6 series of fatty acids) and α-linolenic acid (ALA, C18:3n-3) (precursor to the n-3 series of fatty acids) are the simplest members of each family of PUFA and are termed essential fatty acids as the body cannot synthesise these. PUFA regulate a wide variety of biological functions, depending on the location of the last double bond, which range from blood pressure and blood clotting to the correct development and functioning of the brain and nervous system [2]. In addition, lipid mediators generated from long-chain (LC-) PUFA (arachidonic acid (AA) in the n-6 series and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the n-3 series) have important roles in immune regulation and inflammation [3]. The main dietary sources of LA include plant oils such as sunflower, safflower, and corn oils (Table 1), but they are also present in cereals, animal fat, and wholegrain bread. Rich dietary sources of ALA include green leafy vegetables, flaxseed, and rapeseed oils [2] (Table 1). [Table: PUFA content of dietary components.] Over the last few decades, extreme qualitative nutritional changes have taken place with increased levels of fatty acid consumption [4]. Today, industrialised societies are characterised by an increase in saturated fat, omega 6 PUFA, and trans fatty acid intake, as well as an overall decrease in omega-3 PUFA intake [5]. Fatty acids now represent 28–42% of total energy consumed by European populations [4, 6], whereas, in ancestral nutrition, fatty acid consumption was only approximately 20–30% of total energy [4, 7, 8]. As a result of the increased consumption of LA-rich vegetable oils associated with the Western diet, n-6 PUFA consumption has become progressively much higher than that of n-3 PUFA [9]. Optimal dietary intakes of the n-6 : n-3 ratio should be around 1–4 : 1. However, according to the nutritional changes described above in the Western diet, this ratio has now increased to be within the range of 10 : 1 to 20 : 1 [4]. In parallel, there are coinciding increases in the incidence of diseases involving inflammatory processes such as cardiovascular disease, obesity, IBD, rheumatoid arthritis, and cancer. Neurodegenerative and psychiatric illnesses such as AD and depression are other examples [10]. A study carried out by Hassan and Hanachi, involving 984 Iranian women, suggested that a good dietary pattern rich in fruits, legumes, vegetables, cereals, and fish, rich in n-3 PUFA, can decrease the likelihood of developing the Metabolic Syndrome [11]. Another study performed in France, involving 912 men, concluded that a low consumption of fish rich in n-3 PUFA is associated with a higher probability of developing the Metabolic Syndrome [12]. Thus, high intake of n-6 PUFA, along with low intakes of n-3 PUFA, shifts the physiological state to one that is proinflammatory and prothrombotic with increases in vasospasm, vasoconstriction, and blood viscosity and the development of diseases associated with these conditions. PUFA play an important role in the composition of all cell membranes where they maintain homeostasis for correct membrane protein function and influence membrane fluidity, thus regulating cell signalling processes, cellular functions and gene expression [13]. Other functions of PUFA require their metabolism to more highly unsaturated members of their family. For example, LA is converted to AA (20:4n-6) via γ-linolenic acid (GLA, 18:3n-6) and dihomo-γ-linolenic acid (DGLA, 20:3n-6). By the same set of enzymes, ALA can be converted to EPA (20:5n-3) and DHA (22:6n-3). The primary site for PUFA metabolism is the liver; however, it can also take place in various other tissues [14]. It is these longer chain metabolites of LA and ALA that are of major clinical importance within different organs such as the brain, kidney, and liver [15–17]. Cyclooxygenases (COX) and lipoxygenases (LOX) can convert AA to the 2-series of prostaglandins, the 2-series of thromboxanes, and the 4-series of leukotrienes. These are very important, active and short-lived hormones termed “eicosanoids” which are involved in various pathological processes involving inflammatory conditions such as atherosclerosis, obesity, and IBD [13]. Since PUFA give rise to a variety of biologically active compounds which all have important roles in pathological and physiological processes, a proper understanding is needed regarding the contribution these active compounds have on the coinciding increases in inflammatory diseases seen with the disruption of the balance in the ratio of n-6 : n-3 associated with the Western diet. 2. METABOLISM OF N-6 FATTY ACIDS AND BIOSYNTHESIS OF EICOSANOIDS Linoleic acid can be metabolized to other more unsaturated, long-chain members of the n-6 family by the insertion of additional double bonds during consecutive elongation and desaturation mechanisms (Figure 1). The initial rate limiting desaturation of LA to GLA is catalysed by the enzyme delta-6-desaturase (FADS2) [19]. Elongation then takes place to convert GLA to DGLA, by elongation of very long-chain fatty acids (ELOVL) 5, and finally a cycle of elongation and desaturation by delta-5-desaturase (FADS1) generates AA [20]. [Figure: Metabolism of n-6 and n-3 PUFA. The metabolism of PUFA is a complex process involving several enzymes of desaturation, elongation, and β-oxidation. Shown here is the pathway of both n-6 and n-3 PUFA metabolism to more unsaturated, long-chain members of each family. Also shown are their respective eicosanoid derivatives. Data elaborated from [21].] The importance of the FADS2 gene in LC-PUFA synthesis has recently

Read the complete text